Events & Presentations

Upcoming Events
Date Event Details Remind Me
Nov 30, 2021
Piper Sandler 33rd Annual Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Dec 2, 2021 1:00 PM EST
4th Annual Evercore ISI HealthCONx Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
Dec 3, 2021
18th Global Cardiovascular Clinical Trialists Forum
James Hamilton, MD, MBA, Arrowhead’s senior vice president of discovery & translational medicine, will participate in a panel discussion titled, “Developments in Hypertriglyceridemia Trials”
Archived Events
Date Event Details
Oct 4, 2019 10:05 AM EDT
2019 Cantor Global Healthcare Conference
New York, NY
Vince Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Elemer Piros, Ph.D., Cantor Fitzgerald biotechnology equity research analyst
Sep 20, 2019 4:15 PM CEST
Molecular Therapies for Liver Disease in Alpha-1 Antitrypsin Deficiency
Naples, Italy
Sep 16, 2019 11:00 AM +04
Global Summit On Cardiology & Heart Diseases
Dubai, UAE
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver a keynote presentation titled, “Treating hypertriglyceridemic states with RNA interference – emergence of an exciting new modality to treat cardiovascular diseases”
Sep 16, 2019
Developing Alpha-1 Antitrypsin Therapeutics; FDA Public Workshop
Bethesda, MD
Sep 14, 2019
Alpha-1 UK Support Group Event 2019
Daventry, Northamptonshire, UK
Sep 5, 2019
Citi’s 14th Annual Biotech Conference
Boston, MA
Sep 4, 2019 9:40 AM EDT
Baird's 2019 Global Healthcare Conference
New York, NY
Aug 12, 2019
BTIG Biotechnology Conference 2019
New York, NY
Aug 5, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Third Quarter Results
Jul 17, 2019
Roth RNA Revolution Conference
Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, and Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in panel discussions.